Now available at Life Technologies

In October 2012, Life Technologies acquired Compendia Bioscience, a preeminent cancer bioinformatics company whose products and services are widely used by the pharmaceutical industry, academic researchers, and biotech companies to identify novel gene targets for research and drug development.

Learn more about Compendia Bioscience™ products and services

Life Technologies looks forward to supporting these products and services for cancer researchers in academic and commercial organizations.  

Academic and nonprofit cancer researchers

Free access to Oncomine™ Research Edition is available for nonprofit and academic cancer researchers with a valid institutional email address,† following registration.

Start-ups and small companies

Rapidly prioritize targets based on mutations, copy number variants, and differential expression.

*Compendia Bioscience™ and Oncomine™ products are now available at Life Technologies. Register at Life Technologies to purchase products and request quotes on-line. To gain access to Compendia Bioscience™ products and services today, please contact
†Not available in certain countries where trade is restricted by embargo or other regulations.